GW406108X (Synonyms: GW108X) |
Katalog-Nr.GC60891 |
GW406108X ist ein spezifischer Kif15 (Kinesin-12)-Inhibitor mit einem IC50-Wert von 0,82 uM in ATPase-Assays. GW406108X, ein potenter Autophagie-Inhibitor, zeigt eine kompetitive Hemmung von ATP gegen ULK1 mit einem pIC50 von 6,37 (427 nM). GW406108X hemmt die AktivitÄt der ULK1-Kinase und blockiert den autophagischen Fluss, ohne die vorgeschalteten Signalkinasen mTORC1 und AMPK zu beeintrÄchtigen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1644443-92-4
Sample solution is provided at 25 µL, 10mM.
GW406108X is a specific Kif15 (Kinesin-12) inhibitor with an IC50 of 0.82 uM in ATPase assays. GW406108X, a potent autophagy inhibitor, shows ATP competitive inhibition against ULK1 with a pIC50 of 6.37 (427 nM). GW406108X inhibits ULK1 kinase activity and blocks autophagic flux, without affecting the upstream signalling kinases mTORC1 and AMPK[1][2].
GW406108X acts upon ULK1 and autophagy without affecting mTOR or AMPK activity as shown by monitoring ULK1 pS758 (mTOR site) or pS556 (AMPK site) levels. GW406108X inhibits VPS34 and AMPK with pIC50 of 6.34 (457 nM) and 6.38 (417 nM), respectively. In the presence of 5 µμ GW406108X, the starvation-induced increase in ATG13 phosphorylation is significantly reduced[1].GW406108X inhibits Kif15-N420 ATPase activity by 76%[2].
[1]. Zachari M, et al. The identification and characterisation of autophagy inhibitors from the published kinase inhibitor sets. Biochem J. 2020;477(4):801-814. [2]. Dumas ME, et al. Dual inhibition of Kif15 by oxindole and quinazolinedione chemical probes. Bioorg Med Chem Lett. 2019;29(2):148-154.
Average Rating: 5
(Based on Reviews and 35 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *